340B Report (May 16, 2024) - All entities who participate in the 340B program are subject to an Office of Pharmacy Affairs (OPA) audit regardless of entity type, size or volume of transactions. For the last five years, HRSA’s OPA...
340B Report (May 16, 2024) – All entities who participate in the 340B program are subject to an Office of Pharmacy Affairs (OPA) audit regardless of entity type, size or volume of transactions. For the last five years, HRSA’s OPA has been completing approximately 200 audits a year and, as of May, 2024, 19 audits have been completed. Historically, the entity types at highest risk for audit were disproportionate share hospitals and critical access hospitals. But in the past few years there has been a shift to audit more non-hospital grantees such as Federally Qualified Health Centers, STD clinics, and even specialty clinics. No entity should consider themselves “safe” and all entities should be prepared to receive the dreaded OPA audit notice…
More Articles
Digital sales, software, inventory, and multistate operations can expand a company’s state tax footprint. Understanding where obligations arise can help businesses manage exposure and plan...
In cannabis transactions, key details may carry over after the deal closes. Understand how prior tax filings, Section 280E, and deal structure can shape a...
From the monthly close to internal controls and board reporting, strong financial management depends on a series of interconnected practices. AAFCPAs’ David Kelleher and Lauren...
